Abstract
Regulation of dopamine (DA) release from PC12 cells was investigated. Apomorphine and quinpirole, a selective D2 agonist, significantly reduced K(+)-evoked DA release, and this reduction was reversed by haloperidol. Furthermore, spiroperidol, a selective D2 antagonist, and haloperidol, a nonselective DA antagonist, enhanced the K(+)-evoked DA release. Pertussis toxin treatment of the cells abolished the quinpirole-induced reduction of K(+)-evoked DA release. Also, the haloperidol-induced enhancement of K(+)-evoked DA release was not seen in pertussis toxin treated cells. These results, therefore, suggest the presence of D2 receptors on PC12 cells which result in the modulation of K(+)-evoked DA release via a pertussis toxin-sensitive G protein.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adrenal Gland Neoplasms
-
Animals
-
Apomorphine / pharmacology*
-
Cell Line
-
Dopamine / metabolism
-
Dopamine / physiology*
-
Dopamine Antagonists
-
Ergolines / pharmacology*
-
GTP-Binding Proteins / physiology*
-
Haloperidol / pharmacology
-
Nicotine / pharmacology
-
Pertussis Toxin*
-
Pheochromocytoma
-
Potassium / pharmacology
-
Quinpirole
-
Rats
-
Receptors, Dopamine / drug effects
-
Receptors, Dopamine / physiology
-
Receptors, Dopamine D1
-
Receptors, Dopamine D2
-
Spiperone / pharmacology
-
Virulence Factors, Bordetella / pharmacology*
Substances
-
Dopamine Antagonists
-
Ergolines
-
Receptors, Dopamine
-
Receptors, Dopamine D1
-
Receptors, Dopamine D2
-
Virulence Factors, Bordetella
-
Quinpirole
-
Spiperone
-
Nicotine
-
Pertussis Toxin
-
GTP-Binding Proteins
-
Haloperidol
-
Apomorphine
-
Potassium
-
Dopamine